公开(公告)号：EP1571923A1

公开(公告)日：2005-09-14

申请号：EP03785796.8

申请日：2003-12-11

申请人： Novartis AG

发明人： GIBSON, Glenn R. ,  KOLIDA, Sofia

IPC分类号： A23L1/29 ,  A23L1/0528 ,  A23L1/09

CPC分类号： A23C9/203 ,  A23L5/00 ,  A23L7/00 ,  A23L29/244 ,  A23L29/30 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/28 ,  A23V2250/503 ,  A23V2250/1944 ,  A23V2250/5424 ,  A23V2250/26 ,  A23V2250/062 ,  A23V2250/187 ,  A23V2250/1868 ,  A23V2250/506 ,  A23V2250/628 ,  A23V2250/612 ,  A23V2250/54 ,  A23V2250/70 ,  A23V2250/156 ,  A23V2250/1882 ,  A23V2250/5022

摘要： The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.

公开(公告)号：EP1048226B1

公开(公告)日：2005-08-31

申请号：EP99108405.4

申请日：1999-04-29

申请人： Société des Produits Nestlé S.A.

发明人： Kratky, Zdenek ,  Maire, Jean-Claude

IPC分类号： A23L1/29 ,  A23L1/305 ,  A23L1/30 ,  A23L1/09

CPC分类号： A23L33/19 ,  A23L33/175 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/54252 ,  A23V2250/06 ,  A23V2250/1882 ,  A23V2250/612 ,  A23V2250/70 ,  A23V2250/156 ,  A23V2250/1944 ,  A23V2250/188 ,  A23V2250/5424 ,  A23V2250/54242 ,  A23V2250/0606 ,  A23V2250/0624 ,  A23V2250/0652 ,  A23V2250/0648 ,  A23V2250/065 ,  A23V2250/54246

公开(公告)号：EP1505078A1

公开(公告)日：2005-02-09

申请号：EP02755886.5

申请日：2002-08-08

申请人： San-Ei Gen F.F.I., Inc.

发明人： HAYASHI, Hideo, c/o SAN-EI GEN F.F.I., INC.

IPC分类号： C08B37/00 ,  A23L1/053

CPC分类号： C08B37/0087 ,  A23L5/44 ,  A23L27/70 ,  A23L27/80 ,  A23L29/25 ,  A23L33/12 ,  A23V2002/00 ,  A23V2250/5028 ,  A23V2200/222 ,  A23V2250/1868 ,  A23V2250/1944 ,  A23V2250/211 ,  A23V2200/04

摘要： This invention relates to a technology for modifying gum arabic to increase its emulsifying ability, and provides a method which does not give rise to such troubles as the gum arabic agglomerating to form syrupy masses, sticking to the vessel, dehydration, or charring in the course of processing. Amodified gum arabic with in an increased emulsifying ability can be obtained by heating a roughly crushed or broken solid of gum arabic at a temperature not below 40°C in an atmosphere having a relative humidity of 30-100%. The modified gum arabic can be used with advantage as an emulsifier for beverages, confectionery inclusive of chewing gums, oily flavorings, oily colors, and fat-soluble vitamins, among others.

摘要翻译： 本发明涉及一种改性阿拉伯树胶以提高其乳化能力的技术，并且提供了一种不会引起诸如阿拉伯树胶附聚而形成浆状物质，在容器中粘附于容器，脱水或炭化之类的麻烦的方法 的处理。 具有提高的乳化能力的改性阿拉伯树胶可以通过在相对湿度为30-100％的气氛中在不低于40℃的温度下加热粗糙的阿拉伯胶的粗粉碎或破碎的固体来获得。 改性阿拉伯树胶可以有利地用作饮料，包括口香糖的糖食，油性调味剂，油性色素和脂溶性维生素等等的乳化剂。

公开(公告)号：EP1056359B1

公开(公告)日：2004-09-15

申请号：EP99936019.1

申请日：1999-02-24

申请人： Abbott Laboratories

发明人： DEMICHELE, Stephen, J. ,  WOOD, Steven, M. ,  MCEWEN, John, William

IPC分类号： A23L1/304 ,  A23L1/302 ,  A23L1/30

CPC分类号： A23L33/16 ,  A23L33/12 ,  A23L33/15 ,  A23V2002/00 ,  Y10S514/904 ,  Y10S514/905 ,  A23V2250/54 ,  A23V2250/1944 ,  A23V2250/1842 ,  A23V2250/628 ,  A23V2250/156 ,  A23V2250/032 ,  A23V2250/70 ,  A23V2250/211 ,  A23V2250/5488 ,  A23V2250/54246 ,  A23V2250/5106 ,  A23V2250/606 ,  A23V2250/6406 ,  A23V2250/1626 ,  A23V2250/1614 ,  A23V2250/16 ,  A23V2250/712 ,  A23V2250/708 ,  A23V2250/161 ,  A23V2250/1582 ,  A23V2250/1642 ,  A23V2250/1588 ,  A23V2250/1598 ,  A23V2250/1618

摘要： In its broadest aspect, the present invention is directed to the discovery of immunonutritional products that are useful in reducing the immunological system suppression that results from stress. The stress may be in the form of physical exertion, mental exhaustion, disease states and the like. In one embodiment, the invention relates to a nutritional composition comprising a structured glyceride component and an antioxidant system. This nutritional composition has been shown to be highly effective in reducing immune system down regulation or dysregulation as a result of stress.

公开(公告)号：EP0961552B1

公开(公告)日：2004-06-16

申请号：EP96934726.9

申请日：1996-10-15

申请人： SOCIETE DES PRODUITS NESTLE S.A.

发明人： TRIMBO, Susan, L. ,  KRUSEMAN, Jan ,  KRUZEL, Chris ,  MARK, David, A. ,  REDDY, Sekhar

IPC分类号： A23L1/305 ,  A23L1/30

CPC分类号： A23L33/19 ,  A23L33/12 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/54246 ,  A23V2250/54252 ,  A23V2250/1944 ,  A23V2250/1942 ,  A23V2250/211 ,  A23V2250/5114 ,  A23V2250/628 ,  A23V2250/1842 ,  A23V2250/1882 ,  A23V2250/5118

摘要： An enteral composition for paediatric patients. The composition is made up of a protein source, a carbohydrate source and a lipid source. The protein source provides 10 % to 14 % of the total calories and is in the form of casein and whey. The lipid source is a mixture of medium and long chain triglycerides of which at least 20 % are medium chain triglycerides. The composition may be used for providing nutrition to a paediatric patient; especially patients suffering from cerebral palsy or recovering from trauma, burns or surgery and having moderate needs for tissue repair.

公开(公告)号：EP0994657B1

公开(公告)日：2004-01-28

申请号：EP98928961.6

申请日：1998-06-10

申请人： Abbott Laboratories

发明人： AGOSTA, Phyllis, J., B. ,  BORSCHEL, Marlene, W. ,  REYNOLDS, Patricia, A. ,  CORDLE, Christopher, T. ,  DUSKA-McEVEN, Geralyn, O.

IPC分类号： A23L1/29

CPC分类号： A23L33/175 ,  A23L33/10 ,  A23L33/115 ,  A23L33/15 ,  A23L33/16 ,  A23L33/40 ,  A23V2002/00 ,  Y10S426/801 ,  A23V2250/0608 ,  A23V2250/062 ,  A23V2250/188 ,  A23V2250/1944 ,  A23V2250/70 ,  A23V2250/156 ,  A23V2200/222 ,  A23V2250/06 ,  A23V2250/1874 ,  A23V2250/1872 ,  A23V2250/0644 ,  A23V2250/0612

摘要： This invention relates to a palatable elemental nutritional formula that is nutritionally complete for humans with specialized dietary needs. The nutritional of the present invention uses specific free amino acids to provide the source of amino nitrogen (protein equivalents) and a special blend of fats that provides 38 to 50 % of the total calories in a pleasant tasting formula. The nutritionally complete formula of this invention is useful for children having multiple protein allergies, short gut syndrome, sick gut, diarrhea and the like. More specifically, the nutritional product, in accordance with this invention, utilizes L-asparagine monohydrochloride and L-glutamine in place of L-aspartic acid and L-glutamic acid, respectively. In addition, the source of fat comprises soy, fractionated coconut oil (medium chain triglycerides), high oleic safflower oil and esterified glycerol emulsifiers. The level of fat calories is about 38 to 50 % of total calories, which produces a product having a low osmolarity and provides required energy requirements in a small volume.

公开(公告)号：EP1094824A4

公开(公告)日：2003-04-09

申请号：EP99927472

申请日：1999-06-10

申请人： CRUM ALBERT B ,  ZIVKOVIC D DOROTHY

发明人： CRUM ALBERT B ,  ZIVKOVIC D DOROTHY

IPC分类号： A61K33/04 ,  A23C9/20 ,  A23L1/30 ,  A23L1/304 ,  A23L1/305 ,  A61K35/20 ,  A61K38/17 ,  A61P3/02 ,  A61P37/04 ,  A61P43/00

CPC分类号： A61K35/20 ,  A23C9/206 ,  A23L33/10 ,  A23L33/165 ,  A23L33/19 ,  A23V2002/00 ,  A61K38/1709 ,  A61K2300/00 ,  A23V2250/54252 ,  A23V2250/28 ,  A23V2250/70 ,  A23V2250/1944 ,  A23V2250/506 ,  A23V2250/1626 ,  A23V2250/062 ,  A23V2250/211

摘要： The present invention relates to nutritive compositions containing whey, FOS, and bovine or caprine colostrum for the creation and maintenance of a healthy intestinal flora and for the enhancement of the immune system.

公开(公告)号：EP1294371A1

公开(公告)日：2003-03-26

申请号：EP01965011.8

申请日：2001-06-20

申请人： N.V. Seghers Nutrition Sciences S.A.

发明人： MOLLY, Koen ,  BRUGGEMAN, Geert

IPC分类号： A61K31/20 ,  A61K31/19 ,  A61K31/215 ,  A61K31/23 ,  A23K1/16 ,  A23L3/34

CPC分类号： A23L3/3508 ,  A01N37/02 ,  A23K20/158 ,  A23K50/00 ,  A23K50/60 ,  A23K50/75 ,  A23L3/3499 ,  A23L33/115 ,  A23V2002/00 ,  A01N2300/00 ,  A23V2200/10 ,  A23V2250/1944

摘要： The present invention relates to the use of one or more C6 - C10 medium chain fatty acids (MCFA), salts, derivatives or mixtures or emulsions thereof for the inhibition of microbial contamination, growth and the subsequent toxin production. The MCFA are chosen from the group consisting of caproic (C6) acid, heptanoic (C7) acid, caprylic (C8) acid, nonanoic (C9) acid and capric (C10) acid. The invention further relates to a feed composition for an animal comprising a feed supplement containing one or more medium chain fatty acids (MCFA) chosen from the group consisting of caproic (C6) acid, heptanoic (C7) acid, caprylic (C8) acid, nonanoic (C9) acid and capric (C10) acid, preferably caprylic (C8) acid, and capric (C10) acid, salts, derivatives or mixtures or emulsions thereof.

公开(公告)号：EP1102549A2

公开(公告)日：2001-05-30

申请号：EP99920265.8

申请日：1999-04-30

申请人： Abbott Laboratories

发明人： DeWILLE, Normanella, T. ,  MORRIS, Jeffrey, G. ,  MAZER, Terrence, B. ,  ANLOAGUE, Paul, S. ,  SMELLER, Amanda, L. ,  CHANDLER, Michael, A. ,  GARCIA, Diane, M. ,  NDIFE, Louis, I.

IPC分类号： A23L1/29

CPC分类号： A23L2/66 ,  A23L2/38 ,  A23L33/115 ,  A23L33/15 ,  A23L33/16 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/628 ,  A23V2250/5114 ,  A23V2250/5424 ,  A23V2250/188 ,  A23V2250/032 ,  A23V2250/5072 ,  A23V2250/0616 ,  A23V2250/1944 ,  A23V2250/02 ,  A23V2250/156 ,  A23V2250/51084 ,  A23V2250/54246 ,  A23V2250/5108 ,  A23V2250/708 ,  A23V2250/704 ,  A23V2250/702 ,  A23V2250/712 ,  A23V2250/71 ,  A23V2250/5118 ,  A23V2250/54252

摘要： This invention is directed to a low pH nutritional formula that contains high levels of macronutrients, vitamins and minerals. The pH of the enteral formula is from about 3.0-4.6 and delivers at least 25 % of the RDI for selected vitamins and minerals in a 237 ml. serving. The enteral formula uses a stabilizing system comprising a high methoxy pectin to stabilize the protein and a unique process to produce the formula.

公开(公告)号：EP1077616A1

公开(公告)日：2001-02-28

申请号：EP99924930.3

申请日：1999-05-11

申请人： Novartis Nutrition AG

发明人： LOWRY, Carol, Jo ,  SASS, Kathy, Marie

IPC分类号： A23L1/305 ,  A23L1/30 ,  A61K31/195

CPC分类号： A61K31/198 ,  A23L33/10 ,  A23L33/175 ,  A23L33/40 ,  A23V2002/00 ,  A23V2250/606 ,  A23V2250/188 ,  A23V2250/54246 ,  A23V2250/1944 ,  A23V2250/0606 ,  A23V2250/042 ,  A23V2250/1842 ,  A23V2250/0612 ,  A23V2250/0644 ,  A23V2250/211 ,  A23V2250/70 ,  A23V2250/156

摘要： L-arginine found essential to enhance the glomerular function of the kidneys is used to formulate a low viscosity, calorie-dense, nutritional product for a person having renal failure. In a product free of citric acid or citrates, for oral ingestion, the taste of arginine is counteracted by lactic, malic or adipic acid; in a formulation for tube-feeding, citric acid and citrates in a specific ratio controls the product's stability. The ratio of calcium to phosphorus is controlled, as is the caloric distribution and water content; the amounts of vitamins and minerals included provide a nutritionally complete formulation.